Open access
Jul 2026
Functional restoration of conformational (R175H) and contact (R273H) mutant p53 by Bacillus-derived Hydroxymycotrienin A in non-small cell lung cancer: a computational approach
Hydxymycotrienin A is identified as a promising, bioavailable ‘privileged scaffold’ that offers a non-covalent therapeutic strategy for NSCLC, characterizing Hydroxymycotrienin A as a promising, bioavailable ‘privileged scaffold’ that offers a non-covalent therapeutic strategy.
Adeline Celina Rufus, Sidharth Kumar N, M. Ramasamy et al.
· Frontiers in Bioinformatics · 0 citations